Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Appointed director
|
|
Fibrocell Science, Inc. (FCSC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/07/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/18/2019 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 12/17/2019 |
4
| KIRK RANDAL J (10% Owner) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Converted 10,282 shares
@ $0
Unknown transaction of 80,160 shares
@ $3, valued at
$240.5k
Converted 291 shares
@ $0
Unknown transaction of 2,453 shares
@ $3, valued at
$7.4k
Converted 169,602 shares
@ $0
Unknown transaction of 1,324,328 shares
@ $3, valued at
$4M
Converted 112,617 shares
@ $0
Unknown transaction of 539,337 shares
@ $3, valued at
$1.6M
Converted 106 convertible preferred
@ $0
Converted 3 convertible preferred
@ $0
Converted 1,746 convertible preferred
@ $0 |
|
| 12/13/2019 |
4
| Smith Marcus E. (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 534 options to buy
@ $75, valued at
$40.1k
Disposed/sold 1,600 options to buy
@ $82.35, valued at
$131.8k
Disposed/sold 1,200 options to buy
@ $62.1, valued at
$74.5k
Disposed/sold 2,400 options to buy
@ $81.6, valued at
$195.8k
Disposed/sold 2,400 options to buy
@ $14.25, valued at
$34.2k
Disposed/sold 6,000 options to buy
@ $16.55, valued at
$99.3k
Disposed/sold 6,000 options to buy
@ $2.36, valued at
$14.2k
Disposed/sold 12,000 options to buy
@ $1.94, valued at
$23.3k
|
|
| 12/13/2019 |
4
| Kirk Julian P. (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 534 options to buy
@ $75, valued at
$40.1k
Disposed/sold 1,600 options to buy
@ $82.35, valued at
$131.8k
Disposed/sold 1,200 options to buy
@ $62.1, valued at
$74.5k
Disposed/sold 2,400 options to buy
@ $81.6, valued at
$195.8k
Disposed/sold 2,400 options to buy
@ $14.25, valued at
$34.2k
Disposed/sold 6,000 options to buy
@ $16.55, valued at
$99.3k
Disposed/sold 6,000 options to buy
@ $2.36, valued at
$14.2k
Disposed/sold 12,000 options to buy
@ $1.94, valued at
$23.3k
|
|
| 12/13/2019 |
4
| St.Clare Christine (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 667 shares
@ $3, valued at
$2k
Disposed/sold 534 options to buy
@ $52.5, valued at
$28k
Disposed/sold 1,600 options to buy
@ $82.35, valued at
$131.8k
Disposed/sold 1,200 options to buy
@ $62.1, valued at
$74.5k
Disposed/sold 2,400 options to buy
@ $81.6, valued at
$195.8k
Disposed/sold 2,400 options to buy
@ $16.55, valued at
$39.7k
Disposed/sold 6,000 options to buy
@ $16.55, valued at
$99.3k
Disposed/sold 6,000 options to buy
@ $2.36, valued at
$14.2k
Disposed/sold 12,000 options to buy
@ $1.94, valued at
$23.3k
|
|
| 12/13/2019 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 534 options to buy
@ $56.25, valued at
$30k
Disposed/sold 1,600 options to buy
@ $82.35, valued at
$131.8k
Disposed/sold 1,200 options to buy
@ $62.1, valued at
$74.5k
Disposed/sold 2,400 options to buy
@ $81.6, valued at
$195.8k
Disposed/sold 2,400 options to buy
@ $14.25, valued at
$34.2k
Disposed/sold 6,000 options to buy
@ $16.55, valued at
$99.3k
Disposed/sold 6,000 options to buy
@ $2.36, valued at
$14.2k
Disposed/sold 12,000 options to buy
@ $1.94, valued at
$23.3k
|
|
| 12/13/2019 |
4
| Moore Kelvin (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 304 shares
@ $3, valued at
$912
Disposed/sold 534 options to buy
@ $232.5, valued at
$124.2k
Disposed/sold 534 options to buy
@ $52.5, valued at
$28k
Disposed/sold 1,600 options to buy
@ $82.35, valued at
$131.8k
Disposed/sold 1,200 options to buy
@ $62.1, valued at
$74.5k
Disposed/sold 2,400 options to buy
@ $81.6, valued at
$195.8k
Disposed/sold 2,400 options to buy
@ $14.25, valued at
$34.2k
Disposed/sold 6,000 options to buy
@ $16.55, valued at
$99.3k
Disposed/sold 6,000 options to buy
@ $2.36, valued at
$14.2k
Disposed/sold 12,000 options to buy
@ $1.94, valued at
$23.3k
|
|
| 12/13/2019 |
4
| Maslowski John Michael (CEO) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 3,164 shares
@ $3, valued at
$9.5k
Disposed/sold 908 options to buy
@ $232.5, valued at
$211.1k
Disposed/sold 1,167 options to buy
@ $82.35, valued at
$96.1k
Disposed/sold 1,334 options to buy
@ $74.25, valued at
$99k
Disposed/sold 1,334 options to buy
@ $44.1, valued at
$58.8k
Disposed/sold 6,668 options to buy
@ $52.95, valued at
$353.1k
Disposed/sold 6,667 options to buy
@ $34.05, valued at
$227k
Disposed/sold 16,667 options to buy
@ $9.94, valued at
$165.7k
Disposed/sold 20,000 options to buy
@ $3.45, valued at
$69k
Disposed/sold 100,000 options to buy
@ $1.78, valued at
$178k
|
|
| 12/13/2019 |
4
| Mazur Marc (Director) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 600 shares
@ $3, valued at
$1.8k
Disposed/sold 534 options to buy
@ $390, valued at
$208.3k
Disposed/sold 534 options to buy
@ $232.5, valued at
$124.2k
Disposed/sold 534 options to buy
@ $52.5, valued at
$28k
Disposed/sold 1,600 options to buy
@ $82.35, valued at
$131.8k
Disposed/sold 1,200 options to buy
@ $62.1, valued at
$74.5k
Disposed/sold 2,400 options to buy
@ $81.6, valued at
$195.8k
Disposed/sold 2,400 options to buy
@ $14.25, valued at
$34.2k
Disposed/sold 6,000 options to buy
@ $16.55, valued at
$99.3k
Disposed/sold 6,000 options to buy
@ $2.36, valued at
$14.2k
Disposed/sold 12,000 options to buy
@ $1.94, valued at
$23.3k
|
|
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
4
| Buckley Sean D. (CFO) has filed a Form 4 on Fibrocell Science, Inc.|
Txns:
| Disposed/sold 200 options to buy
@ $232.5, valued at
$46.5k
Disposed/sold 334 options to buy
@ $82.35, valued at
$27.5k
Disposed/sold 1,000 options to buy
@ $63.6, valued at
$63.6k
Disposed/sold 2,229 options to buy
@ $11.25, valued at
$25.1k
Disposed/sold 4,000 options to buy
@ $11.25, valued at
$45k
Disposed/sold 5,000 options to buy
@ $3.45, valued at
$17.3k
Disposed/sold 30,000 options to buy
@ $1.78, valued at
$53.4k
Disposed/sold 15,000 options to buy
@ $1.82, valued at
$27.3k
|
|
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 12/13/2019 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 12/13/2019 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 12/13/2019 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 12/10/2019 |
8-K
| Quarterly results |
| 11/14/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 11/12/2019 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 11/01/2019 |
GN
| Shareholder Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – FCSC, PRTO, ARTX, ROAN |
| 10/28/2019 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
|
|
|